Evidence map›Paper›PMID 28811829›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2017

Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome.

Fangfang Tao, Ping Lü, Chunbo Xu, Mengmeng Zheng, Wenhong Liu, Minhe Shen, Shanming Ruan

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Fangfang TaoDepartment of Immunology and Microbiology, Basic Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Ping LüDepartment of Traditional Chinese Medicine, Taizhou First People's Hospital, Taizhou, Zhejiang, China.ORCID 0000-0002-1680-3241
Chunbo XuDepartment of Internal Medicine, Yuyao Hospital of Traditional Chinese Medicine, Yuyao, Zhejiang, China.ORCID 0000-0001-7657-4041
Mengmeng ZhengDepartment of Medical Oncology, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenzhou, Zhejiang, China.ORCID 0000-0003-0276-0516
Wenhong LiuDepartment of Immunology and Microbiology, Basic Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.ORCID 0000-0002-9202-0687
Minhe ShenDepartment of Medical Oncology, The First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Shanming RuanDepartment of Medical Oncology, The First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.ORCID 0000-0003-1061-5255
Zhejiang Chinese Medical University · CNTaizhou First People's Hospital · CNWenzhou Hospital of Traditional Chinese Medicine · CNYuxian People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer is one of the leading causes of tumor-associated death, and traditional Chinese medicine (TCM) classifies colorectal cancer into various subtypes mainly according to the symptomatic pattern identification

Identifiers

PMID28811829
PMCPMC5546053
OpenAlexW2736747316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.